Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats

  • Izquierdo Bouldstridge, Andrea
  • Bustillos, Alberto
  • Bonet-Costa, Carles
  • Aribau-Miralbés, Patricia
  • García-Gomis, Daniel
  • Dabad, Marc
  • Esteve-Codina, Anna
  • Pascual-Reguant, Laura, 1990-
  • Peiró Sales, Sandra
  • Esteller, Manel
  • Murtha, Matthew
  • Millán Ariño, Lluís, 1984-
  • Jordan Vallès, Albert
Histone H1 has seven variants in human somatic cells and contributes to chromatin compaction and transcriptional regulation. Knock-down (KD) of each H1 variant in breast cancer cells results in altered gene expression and proliferation differently in a variant specific manner with H1.2 and H1.4 KDs being most deleterious. Here we show combined depletion of H1.2 and H1.4 has a strong deleterious effect resulting in a strong interferon (IFN) response, as evidenced by an up-regulation of many IFN-stimulated genes (ISGs) not seen in individual nor in other combinations of H1 variant KDs. Although H1 participates to repress ISG promoters, IFN activation upon H1.2 and H1.4 KD is mainly generated through the activation of the IFN response by cytosolic nucleic acid receptors and IFN synthesis, and without changes in histone modifications at induced ISG promoters. H1.2 and H1.4 co-KD also promotes the appearance of accessibility sites genome wide and, particularly, at satellites and other repeats. The IFN response may be triggered by the expression of noncoding RNA generated from heterochromatic repeats or endogenous retroviruses upon H1 KD. In conclusion, redundant H1-mediated silencing of heterochromatin is important to maintain cell homeostasis and to avoid an unspecific IFN response., Spanish Ministry of Economy and Competitiveness (MINECO) and European Regional Development Fund [BFU2014–52237-P]. A.B. received a predoctoral fellowship from SENESCYT from Ecuador. M.D. was recipient of a fellowship from MINECO [PTA2014–09515-I]. A.E.-C. was funded by the RED-BIO project of the Spanish National Bioinformatics Institute (INB) [PT13/0001/0044]. The INB is funded by the Spanish National Health Institute Carlos III (ISCIII) and MINECO. Funding for open access charge: Spanish Ministry of Economy and Competitiveness (MINECO) and European Regional Development Fund [BFU2014-52237-P].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SETD7 regulates the differentiation of human embryonic stem cells

  • Castaño, Julio
  • Morera, Cristina
  • Sesé, Borja
  • Boué, Stéphanie
  • Bonet-Costa, Carles
  • Martí, Mercè
  • Roque, Alicia
  • Jordan, Albert
  • Barrero, María José
The successful use of specialized cells in regenerative medicine requires an optimization in the differentiation protocols that are currently used. Understanding the molecular events that take place during the differentiation of human pluripotent cells is essential for the improvement of these protocols and the generation of high quality differentiated cells. In an effort to understand the molecular mechanisms that govern differentiation we identify the methyltransferase SETD7 as highly induced during the differentiation of human embryonic stem cells and differentially expressed between induced pluripotent cells and somatic cells. Knock-down of SETD7 causes differentiation defects in human embryonic stem cell including delay in both the silencing of pluripotency-related genes and the induction of differentiation genes. We show that SETD7 methylates linker histone H1 in vitro causing conformational changes in H1. These effects correlate with a decrease in the recruitment of H1 to the pluripotency genes OCT4 and NANOG during differentiation in the SETD7 knockdown that might affect the proper silencing of these genes during differentiation., M.J.B. was partially supported by the Ramón y Cajal program of MEC (RYC-2007-01510). B.S. was a recipient of a predoctoral fellowship from MEC (BES-2008-009567). C.M. was supported by PT13/0001/0041 PRB2-ISCIII-SGEFI- FEDER-PE I+D+i 2013-2016. J.C. was partially supported by Fundación CELLEX. This work was partially supported by grant RD12/0019/0034 TERCEL-RETICS-ISCIII-MINECO-FEDER, grant SAF2009-08588 from MICINN to M.J.B and grant BFU2014-52237 to A.J., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats

  • Izquierdo-Bouldstridge, Andrea
  • Bustillos, Alberto
  • Bonet-Costa, Carles
  • Aribau-Miralbés, Patricia
  • García-Gomis, Daniel
  • Dabad, Marc
  • Esteve-Codina, Anna
  • Pascual-Reguant, Laura
  • Peiró, Sandra
  • Esteller, Manel
  • Murtha, Matthew
  • Millán-Ariño, Lluis
  • Jordan, Albert
Histone H1 has seven variants in human somatic cells and contributes to chromatin compaction and transcriptional regulation. Knock-down (KD) of each H1 variant in breast cancer cells results in altered gene expression and proliferation differently in a variant specific manner with H1.2 and H1.4 KDs being most deleterious. Here we show combined depletion of H1.2 and H1.4 has a strong deleterious effect resulting in a strong interferon (IFN) response, as evidenced by an up-regulation of many IFN-stimulated genes (ISGs) not seen in individual nor in other combinations of H1 variant KDs. Although H1 participates to repress ISG promoters, IFN activation upon H1.2 and H1.4 KD is mainly generated through the activation of the IFN response by cytosolic nucleic acid receptors and IFN synthesis, and without changes in histone modifications at induced ISG promoters. H1.2 and H1.4 co-KD also promotes the appearance of accessibility sites genome wide and, particularly, at satellites and other repeats. The IFN response may be triggered by the expression of noncoding RNA generated from heterochromatic repeats or endogenous retroviruses upon H1 KD. In conclusion, redundant H1-mediated silencing of heterochromatin is important to maintain cell homeostasis and to avoid an unspecific IFN response., Spanish Ministry of Economy and Competitiveness (MINECO) and European Regional Development Fund [BFU2014–52237-P]. A.B. received a predoctoral fellowship from SENESCYT from Ecuador. M.D. was recipient of a fellowship from MINECO [PTA2014– 09515-I]. A.E.-C. was funded by the RED-BIO project of the Spanish National Bioinformatics Institute (INB) [PT13/0001/0044]. The INB is funded by the Spanish National Health Institute Carlos III (ISCIII) and MINECO. Funding for open access charge: Spanish Ministry of Economy and Competitiveness (MINECO) and European Regional Development Fund [BFU2014-52237-P]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A new quinoline BRD4 inhibitor targets a distinct latent HIV-1 reservoir for reactivation from other “shock” drugs

  • Abner, Erik
  • Stoszko, Mateusz
  • Zeng, Lei
  • Chen, Heng-Chang
  • Izquierdo-Bouldstridge, Andrea
  • Konuma, Tsuyoshi
  • Zorita, Eduard
  • Fanunza, Elisa
  • Zhang, Qiang
  • Mahmoudi, Tokameh
  • Zhou, Ming-Ming
  • Filion, Guillaume J.
  • Jordan, Albert
Upon HIV-1 infection, a reservoir of latently infected resting T cells prevents the eradication of the virus from patients. To achieve complete depletion, the existing virus-suppressing antiretroviral therapy must be combined with drugs that reactivate the dormant viruses. We previously described a novel chemical scaffold compound, MMQO (8-methoxy-6-methylquinolin-4-ol), that is able to reactivate viral transcription in several models of HIV latency, including J-Lat cells, through an unknown mechanism. MMQO potentiates the activity of known latency-reversing agents (LRAs) or “shock” drugs, such as protein kinase C (PKC) agonists or histone deacetylase (HDAC) inhibitors. Here, we demonstrate that MMQO activates HIV-1 independently of the Tat transactivator. Gene expression microarrays in Jurkat cells indicated that MMQO treatment results in robust immunosuppression, diminishes expression of c-Myc, and causes the dysregulation of acetylation-sensitive genes. These hallmarks indicated that MMQO mimics acetylated lysines of core histones and might function as a bromodomain and extraterminal domain protein family inhibitor (BETi). MMQO functionally mimics the effects of JQ1, a well-known BETi. We confirmed that MMQO interacts with the BET family protein BRD4. Utilizing MMQO and JQ1, we demonstrate how the inhibition of BRD4 targets a subset of latently integrated barcoded proviruses distinct from those targeted by HDAC inhibitors or PKC pathway agonists. Thus, the quinoline-based compound MMQO represents a new class of BET bromodomain inhibitors that, due to its minimalistic structure, holds promise for further optimization for increased affinity and specificity for distinct bromodomain family members and could potentially be of use against a variety of diseases, including HIV infection., This work was supported by funding from the Spanish Ministry of Economy and Competitiveness (MINECO); the European Regional Development Fund (grant BFU2014-52237-P); Fundación para la Investigación y Prevención del SIDA en España (FIPSE 360946/10; to A.J.); ERC Synergy Grant 609989; Centro de Excelencia Severo Ochoa 2013-2017, SEV-2012-0208; and Plan Nacional BFU2012-37168 (to G.J.F.). The work was also supported in part by the research fund of the First Hospital of Jilin University (Changchun, China), grants from the National Institutes of Health (to M.-M.Z.) and the European Research Council under the European Union’s Seventh Framework Programme (FP/2007-2013)/ERC STG 337116 Trxn-PURGE, and Dutch AIDS Fonds grants 2014021 and an ErasmusMC research grant (to T.M.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Epigenetic mechanisms in health and disease: BCEC 2017

  • Carbonell, Albert
  • Fueyo, Raquel
  • Izquierdo-Bouldstridge, Andrea
  • Moreta, Cristina
  • Jordan, Albert
The Barcelona Conference on Epigenetics and Cancer (BCEC) entitled “Epigenetic Mechanisms in Health and Disease” was held in Barcelona, October 26-26, 2017. The 2017 BCEC was the fifth and last edition of a series of annual conferences organized as a joint effort of five leading Barcelona research institutes together with B-Debate. This edition was organized by Albert Jordan from the Molecular Biology Institute of Barcelona (IBMB-CSIC) and Marcus Bushbeck from the Josep Carreras Leukaemia Research Institute (IJC). Jordi Bernués, Marian Martínez-Balbás, and Ferran Azorín were also part of the scientific committee. In 22 talks and 51 posters, researchers presented their latest results in the fields of histone variants, epigenetic regulation, and chromatin 3D organization to an audience of around 250 participants from 16 countries. This year, a broad number of talks focused on the epigenetic causes and possible related treatments of complex diseases such as cancer. Participants at the 2017 BCEC elegantly closed the series, discussing progress made in the field of epigenetics and highlighting its role in human health and disease, RF was supported by a FPU fellowship [grant number FPU13/01384]. AI- B was supported by a grant from Spanish Ministry of Economy and Com- petitiveness (MINECO) and European Regional Development Fund [grant number BFU2014–52237-P] to Dr. Albert Jordan. CM was supported by grants from Instituto de Salud Carlos III [grant number PIE16-00011]; and Fundaci on Olga Torres to Dr. Sonia-Vanina Forcales. AC was sup- ported by grants from MINECO [grant number BFU2012-30724] and [grant number BFU2015-65082P], the Generalitat de Catalunya [grant number SGR2009-1023] and [grant number SGR2014-204], and the Euro- pean Community FEDER program to Dr. Ferran Azor ın., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats

  • Izquierdo Bouldstridge, Andrea
  • Bustillos, Alberto
  • Bonet-Costa, Carles
  • Aribau-Miralbés, Patricia
  • García-Gomis, Daniel
  • Dabad, Marc
  • Esteve-Codina, Anna
  • Pascual-Reguant, Laura, 1990-
  • Peiró Sales, Sandra
  • Esteller, Manel
  • Murtha, Matthew
  • Millán Ariño, Lluís, 1984-
  • Jordan Vallès, Albert
Histone H1 has seven variants in human somatic cells and contributes to chromatin compaction and transcriptional regulation. Knock-down (KD) of each H1 variant in breast cancer cells results in altered gene expression and proliferation differently in a variant specific manner with H1.2 and H1.4 KDs being most deleterious. Here we show combined depletion of H1.2 and H1.4 has a strong deleterious effect resulting in a strong interferon (IFN) response, as evidenced by an up-regulation of many IFN-stimulated genes (ISGs) not seen in individual nor in other combinations of H1 variant KDs. Although H1 participates to repress ISG promoters, IFN activation upon H1.2 and H1.4 KD is mainly generated through the activation of the IFN response by cytosolic nucleic acid receptors and IFN synthesis, and without changes in histone modifications at induced ISG promoters. H1.2 and H1.4 co-KD also promotes the appearance of accessibility sites genome wide and, particularly, at satellites and other repeats. The IFN response may be triggered by the expression of noncoding RNA generated from heterochromatic repeats or endogenous retroviruses upon H1 KD. In conclusion, redundant H1-mediated silencing of heterochromatin is important to maintain cell homeostasis and to avoid an unspecific IFN response., Spanish Ministry of Economy and Competitiveness (MINECO) and European Regional Development Fund [BFU2014–52237-P]. A.B. received a predoctoral fellowship from SENESCYT from Ecuador. M.D. was recipient of a fellowship from MINECO [PTA2014–09515-I]. A.E.-C. was funded by the RED-BIO project of the Spanish National Bioinformatics Institute (INB) [PT13/0001/0044]. The INB is funded by the Spanish National Health Institute Carlos III (ISCIII) and MINECO. Funding for open access charge: Spanish Ministry of Economy and Competitiveness (MINECO) and European Regional Development Fund [BFU2014-52237-P].
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SETD7 Regulates the Differentiation of Human Embryonic Stem Cells

  • Castaño Cardoso, Julio|||0000-0002-0712-5856
  • Morera, Cristina
  • Sesé, Borja
  • Boue, Stephanie|||0000-0003-0680-4168
  • Bonet-Costa, Carles
  • Martí, Mercè|||0000-0002-1846-0043
  • Roque Córdova, Alicia|||0000-0002-6206-6481
  • Jordan, Albert|||0000-0002-3970-8693
  • Barrero, María José
The successful use of specialized cells in regenerative medicine requires an optimization in the differentiation protocols that are currently used. Understanding the molecular events that take place during the differentiation of human pluripotent cells is essential for the improvement of these protocols and the generation of high quality differentiated cells. In an effort to understand the molecular mechanisms that govern differentiation we identify the methyltransferase SETD7 as highly induced during the differentiation of human embryonic stem cells and differentially expressed between induced pluripotent cells and somatic cells. Knock-down of SETD7 causes differentiation defects in human embryonic stem cell including delay in both the silencing of pluripotency-related genes and the induction of differentiation genes. We show that SETD7 methylates linker histone H1 in vitro causing conformational changes in H1. These effects correlate with a decrease in the recruitment of H1 to the pluripotency genes OCT4 and NANOG during differentiation in the SETD7 knock down that might affect the proper silencing of these genes during differentiation.